CytoDyn Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-1.1M | $1.8M |
| FY2018 | — | $-13.2M | $1.2M |
| FY2019 | — | $-8.9M | $2.6M |
| FY2020 | — | $-2.5M | $14.3M |
| FY2021 | $64.8M | $-21.0M | $33.9M |
| FY2022 | $42.2M | $-94.4M | $4.2M |
| FY2023 | $45.7M | $-109.5M | $2.5M |
| FY2024 | $45.0M | $-116.8M | $3.1M |
| FY2025 | $45.4M | $-96.0M | $11.9M |
| FY2026 | $38.3M | $-109.7M | $11.9M |